These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36122786)
1. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy. Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786 [TBL] [Abstract][Full Text] [Related]
2. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems. Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions. McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097 [TBL] [Abstract][Full Text] [Related]
4. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection. Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610 [TBL] [Abstract][Full Text] [Related]
5. Characterization of co-amorphous carvedilol-maleic acid system prepared by solvent evaporation. Furuishi T; Sato-Hata N; Fukuzawa K; Yonemochi E Pharm Dev Technol; 2023; 28(3-4):309-317. PubMed ID: 36946594 [TBL] [Abstract][Full Text] [Related]
6. Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS. Pajula K; Hyyryläinen J; Koistinen A; Leskinen JTT; Korhonen O Eur J Pharm Biopharm; 2020 May; 150():43-49. PubMed ID: 32151730 [TBL] [Abstract][Full Text] [Related]
7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling. Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332 [TBL] [Abstract][Full Text] [Related]
10. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
11. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study. Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time. Martínez LM; Videa M; Sosa NG; Ramírez JH; Castro S Molecules; 2016 Dec; 21(12):. PubMed ID: 27983640 [TBL] [Abstract][Full Text] [Related]
13. A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs. Ueda H; Muranushi N; Sakuma S; Ida Y; Endoh T; Kadota K; Tozuka Y Pharm Res; 2016 Apr; 33(4):1018-29. PubMed ID: 26700604 [TBL] [Abstract][Full Text] [Related]
14. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin. Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228 [TBL] [Abstract][Full Text] [Related]
15. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters. Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874 [TBL] [Abstract][Full Text] [Related]
16. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436 [TBL] [Abstract][Full Text] [Related]
17. Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions. Yang Z; Nollenberger K; Albers J; Craig D; Qi S Pharm Res; 2015 Apr; 32(4):1210-28. PubMed ID: 25270572 [TBL] [Abstract][Full Text] [Related]
18. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Huang Y; Zhang Q; Wang JR; Lin KL; Mei X Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301 [TBL] [Abstract][Full Text] [Related]
19. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs. Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872 [TBL] [Abstract][Full Text] [Related]
20. DSC, FTIR and Raman Spectroscopy Coupled with Multivariate Analysis in a Study of Co-Crystals of Pharmaceutical Interest. Garbacz P; Wesolowski M Molecules; 2018 Aug; 23(9):. PubMed ID: 30149571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]